Till R E, Beckwith B E
Peptides. 1985 May-Jun;6(3):397-402. doi: 10.1016/0196-9781(85)90103-2.
DDAVP has been shown to facilitate memory, especially retrieval, in humans. Healthy young male adult subjects received DDAVP (60 micrograms) in a cross-over design with a one-week interval between sessions. Results indicated that DDAVP improved immediate memory during the first but not the second testing session, particularly for low-verbal subjects. Treatment with DDAVP also facilitated delayed (one-week) recall in the opposite group, a cross-over interaction that suggests a retrieval locus for the DDAVP effect. Furthermore, since DDAVP improved immediate memory more for low-verbal subjects and delayed memory more for high-verbal subjects, it appears that individual difference factors will be important in understanding the effects of vasopressin on memory.
去氨加压素已被证明可促进人类的记忆,尤其是记忆提取。健康的年轻成年男性受试者在交叉设计中接受了去氨加压素(60微克),各疗程之间间隔一周。结果表明,去氨加压素在第一次而非第二次测试疗程中改善了即时记忆,对语言能力较低的受试者尤为明显。去氨加压素治疗还促进了另一组受试者的延迟(一周)回忆,这种交叉效应表明去氨加压素的作用位点在记忆提取方面。此外,由于去氨加压素对语言能力较低的受试者即时记忆改善更明显,对语言能力较高的受试者延迟记忆改善更明显,因此个体差异因素对于理解加压素对记忆的影响可能很重要。